US2017000758A1PendingUtilityA1

Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

Assignee: GALDERMA RES & DEVPriority: Dec 21, 2001Filed: Sep 19, 2016Published: Jan 5, 2017
Est. expiryDec 21, 2021(expired)· nominal 20-yr term from priority
A61P 35/00A61K 31/20A61K 31/327A61K 9/06A61K 9/0014A61K 31/19A61P 17/14A61K 47/10A61K 47/32A61K 31/07A61K 47/06A61P 17/00A61P 17/10A61K 31/192
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Dermatological/cosmetic compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise, in a physiologically acceptable medium, (i) at least one dispersed retinoid, (ii) dispersed benzoyl peroxide, in free or encapsulated form, and (iii) at least one pH-independent gelling agent, selected from the group consisting of (a) polyacrylamide gelling agents, (b) gelling agents which are acrylic polymers coupled to hydrophobic chains, (c) modified starch gelling agents, and mixture thereof, said composition maintaining good chemical stability of (i) and (ii) without their degradation over time at a temperature of between 4° C. and 40° C.

Claims

exact text as granted — not AI-modified
1 - 34 . (canceled) 
     
     
         35 . A physiologically acceptable aqueous gel composition for treatment of common acne comprising:
 (1) anti-acne actives consisting of:
 0.05% to 1% adapalene and/or at least one pharmaceutically acceptable salt thereof, and 
 2.5% to 5% dispersed benzoyl peroxide; and 
   (2) 2% to 5% polyacrylamide/C13-14 isoparaffin/laureth-7 gelling agent,   said percentages being based on the weight of the total aqueous gel composition for treatment of common acne,   
     
     
         36 . The physiologically acceptable aqueous gel composition of  claim 35  comprising 3.5% to 4% polyacrylamide/C13-14 isoparaffin/laureth-7 gelling agent, said percentages being based on the weight of the total aqueous gel composition for treatment of common acne. 
     
     
         37 . The physiologically acceptable aqueous gel composition of  claim 35  comprising anti-acne actives consisting of:
 0.1% adapalene and/or at least one pharmaceutically acceptable salt thereof, 
 and 
 2.5% dispersed benzoyl peroxide 
 said percentages being based on the weight of the total aqueous gel composition for treatment of common acne. 
 
     
     
         38 . The physiologically acceptable aqueous gel composition of  claim 35  comprising anti-acne actives consisting of:
 0.3% adapalene and/or at least one pharmaceutically acceptable salt thereof, 
 and 
 2.5% dispersed benzoyl peroxide 
 said percentages being based on the weight of the total aqueous gel composition for treatment of common acne. 
 
     
     
         39 . A method for treating common acne comprising administering, to a subject in need thereof, a physiologically acceptable aqueous gel composition for treatment of common acne comprising:
 (1) anti-acne actives consisting of:
 0.05% to 1% adapalene and/or at least one pharmaceutically acceptable salt thereof, and 
 2.5% to 5% dispersed benzoyl peroxide; and 
   (2) 2% to 5% polyacrylamide/C13-14 isoparaffin/laureth-7 gelling agent,   said percentages being based on the weight of the total aqueous gel composition for treatment of common acne.   
     
     
         40 . The method of  claim 39 , wherein the physiologically acceptable aqueous gel composition comprises 3.5% to 4% polyacrylamide/C13-14 isoparaffin/laureth-7 gelling agent, said percentages being based on the weight of the total aqueous gel composition for treatment of common acne. 
     
     
         41 . The method of  claim 39 , wherein the physiologically acceptable aqueous gel composition is administered once daily. 
     
     
         42 . The method of  claim 39 , wherein the physiologically acceptable aqueous gel composition comprises anti-acne actives consisting of:
 0.1% adapalene and/or at least one pharmaceutically acceptable salt thereof,   and   2.5% dispersed benzoyl peroxide   said percentages being based on the weight of the total aqueous gel composition for treatment of common acne.   
     
     
         43 . The method of  claim 39 , wherein the physiologically acceptable aqueous gel composition comprises anti-acne actives consisting of:
 0.3% adapalene and/or at least one pharmaceutically acceptable salt thereof,   and   2.5% dispersed benzoyl peroxide   said percentages being based on the weight of the total aqueous gel composition for treatment of common acne.   
     
     
         44 . A product for treatment of common acne comprising:
 a container; and   a physiologically acceptable aqueous gel composition for treatment of common acne comprising:   (1) anti-acne actives consisting of:
 0.05% to 1% adapalene and/or at least one pharmaceutically acceptable salt thereof, and 
 2.5% to 5% dispersed benzoyl peroxide; and 
   (2) 2% to 5% polyacrylamide/C13-14 isoparaffin/laureth-7 gelling agent,   said percentages being based on the weight of the total aqueous gel composition for treatment of common acne,   wherein the container contains the aqueous gel composition for treatment of common acne.   
     
     
         45 . The product of  claim 44 , wherein the physiologically acceptable aqueous gel composition for treatment of common acne comprises polyacrylamide/C13-14 isoparaffin/laureth-7 gelling agent, said percentages being based on the weight of the total aqueous gel composition. 
     
     
         46 . The product of  claim 44 , wherein the physiologically acceptable aqueous gel composition comprises anti-acne actives consisting of:
 0.1% adapalene and/or at least one pharmaceutically acceptable salt thereof,   and   2.5% dispersed benzoyl peroxide   said percentages being based on the weight of the total aqueous gel composition for treatment of common acne.   
     
     
         47 . The product of  claim 44 , wherein physiologically acceptable aqueous gel composition comprises anti-acne actives consisting of:
 0.3% adapalene and/or at least one pharmaceutically acceptable salt thereof,   and   2.5% dispersed benzoyl peroxide   said percentages being based on the weight of the total aqueous gel composition for treatment of common acne.

Join the waitlist — get patent alerts

Track US2017000758A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.